Castleark Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.64M Buy
+73,500
New +$4.3M 0.17% 127
2023
Q3
– Sell
-61,310
Closed -$3.42M – 316
2023
Q2
$3.42M Buy
+61,310
New +$3.32M 0.16% 140

Other funds holding TXG

Castleark Management's TXG Position: Q3 2026 in Review

Castleark Management opened a new position in 10x Genomics (TXG) in Q3 2026: 73,500 shares worth $6.64M. The stake represents 0.17% of the portfolio and ranks #127 among its holdings. This is a return to the name: Castleark Management previously reported a position in TXG as recently as Q2 2023.

Castleark Management first reported a position in TXG in Q2 2023 and has held it in 2 quarters since. 488 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Castleark Management held 73,500 shares of 10x Genomics worth $6.64M as of Q3 2026.
  • 10x Genomics was a new Castleark Management position in Q3 2026.
  • 10x Genomics made up 0.17% of Castleark Management's portfolio in Q3 2026, its #127 holding.
  • Castleark Management first reported a position in 10x Genomics in Q2 2023 and has held it in 2 quarters since.
  • 488 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Castleark Management's 13F filing for Q3 2026, filed 16 Nov 2026.